Top

Irish Journal of Medical Science (1971 -)

Published in:

01-11-2020 | Acute Kidney Injury | Review Article

COVID-19 in adults: test menu for hospital blood science laboratories

Authors: Paula M. O’Shea, Graham Robert Lee, Tomás P. Griffin, Vincent Tormey, Amjad Hayat, Seán J. Costelloe, Damian Gerard Griffin, Saradha Srinivasan, Maurice O’Kane, Conor M. Burke, John Faul, Christopher J. Thompson, Gerard Curley, William P. Tormey

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2020

Abstract

Introduction

Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.

Objective

To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.

Methods

Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.

Results

We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.

Conclusion

Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 83. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200412-sitrep-83-covid-19.pdf?sfvrsn=697ce98d_4. Accesed: April 12, 2020

Lippi G, Plebani M (2020) The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-0240

Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034CrossRef

Ruan Q, Yang K, Wang W et al (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. https://doi.org/10.1007/s00134-020-05991-x

Lippi G, Plebani M (2020) Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 505:190–191CrossRef

Alhazzani W, Moller MH, Arabi YM et al (2020) Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. https://doi.org/10.1097/CCM.0000000000004363

Lippi G, Plebani M (2020) Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-0198

Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19 et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720CrossRef

Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef

10.

Wang D, Hu B, Hu C et al (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585

11.

Hamming I, Timens W, Bulthuis ML et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637CrossRef

12.

Vaduganathan M, Vardeny O, Michel T et al (2020) Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653–1659CrossRef

13.

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062CrossRef

14.

Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–838CrossRef

15.

Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef

16.

Simmons J, Pittet JF (2015) The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 28:227–236CrossRef

17.

Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. https://doi.org/10.1016/j.thromres.2020.04.013

18.

Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353CrossRef

19.

Nguyen JL, Yang W, Ito K et al (2016) Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 1:274–281CrossRef

20.

Smeeth L, Thomas SL, Hall AJ et al (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351:2611–2618CrossRef

21.

Shi S, Qin M, Shen B et al (2020) Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.0950

22.

Gheblawi M, Wang K, Viveiros A et al (2020) Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ Res. https://doi.org/10.1161/CIRCRESAHA.120.317015

23.

Inciardi RM, Lupi L, Zaccone G et al (2020) Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1096

24.

Bonow RO, Fonarow GC, O'Gara PT et al (2020) Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1105

25.

Guo T, Fan Y, Chen M et al (2020) Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1017

26.

Griffin TP, Wall D, Blake L et al (2020) Vitamin D status of adults in the community, in outpatient clinics, in hospital and in nursing homes in the West of Ireland. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glaa010

27.

Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9:601–604CrossRef

28.

Komolmit P, Charoensuk K, Thanapirom K et al (2017) Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial. PLoS One 12:e0174608CrossRef

29.

Sadeghi K, Wessner B, Laggner U et al (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36:361–370CrossRef

30.

McCartney DM, Byrne DG (2020) Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Ir Med J 113:58PubMed

Title: COVID-19 in adults: test menu for hospital blood science laboratories
Authors: Paula M. O’Shea
Graham Robert Lee
Tomás P. Griffin
Vincent Tormey
Amjad Hayat
Seán J. Costelloe
Damian Gerard Griffin
Saradha Srinivasan
Maurice O’Kane
Conor M. Burke
John Faul
Christopher J. Thompson
Gerard Curley
William P. Tormey
Publication date: 01-11-2020
Publisher: Springer London
Keywords: Acute Kidney Injury
SARS-CoV-2
COVID-19
Acute Kidney Injury
Published in: Irish Journal of Medical Science (1971 -) / Issue 4/2020
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-020-02252-0

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Introduction

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Too old for a paediatric emergency department? It’s complex

Medicine and heuristics: cognitive biases and medical decision-making

Bypass: an integrated hip fracture care pathway

Evaluation of biochemical and clinical effects of hyaluronic acid on non-surgical periodontal treatment: a randomized controlled trial